HCRx buys into Utebzi milestones and royalties, GSK grants exclusive license for Utebzi, and Spero in-licenses SP001 from Innovent Biologics.
1 report, 1 independent
Updated Jul 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
HCRx buys into Utebzi milestones and royalties, GSK grants exclusive license for Utebzi, and Spero in-licenses SP001 from Innovent Biologics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
GSK
British multinational pharmaceutical and biotechnology company
-
Innovent Biologics
Chinese Biopharmaceutical Company
Nothing else this week.